In obese adults without diabetes, does treatment with tirzepatide (a glucose-dependent insulinotropic polypeptide [GIP] and glucagon-like peptide-1 [GLP-1] receptor agonist) lead to improved weight loss outcomes compared with pure GLP-1 receptor agonists? | Researchclopedia
In obese adults without diabetes, does treatment with tirzepatide (a glucose-dependent insulinotropic polypeptide [GIP] and glucagon-like peptide-1 [GLP-1] receptor agonist) lead to improved weight loss outcomes compared with pure GLP-1 receptor agonists?